155 related articles for article (PubMed ID: 11238101)
1. In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpression of beta-glucuronidase can delay onset of clinical signs.
Casal ML; Wolfe JH
Blood; 2001 Mar; 97(6):1625-34. PubMed ID: 11238101
[TBL] [Abstract][Full Text] [Related]
2. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII.
Barker JE; Deveau S; Lessard M; Hamblen N; Vogler C; Levy B
Blood Cells Mol Dis; 2001; 27(5):861-73. PubMed ID: 11783949
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
[TBL] [Abstract][Full Text] [Related]
4. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
[TBL] [Abstract][Full Text] [Related]
5. Donor cell expansion is delayed following nonablative in utero transplantation to treat murine mucopolysaccharidosis type VII.
Barker JE; Schuldt AJ; Lessard ML; Jude CD; Vogler CA; Soper BW
Exp Hematol; 2003 Nov; 31(11):1112-8. PubMed ID: 14585377
[TBL] [Abstract][Full Text] [Related]
6. Transgene produces massive overexpression of human beta -glucuronidase in mice, lysosomal storage of enzyme, and strain-dependent tumors.
Vogler C; Galvin N; Levy B; Grubb J; Jiang J; Zhou XY; Sly WS
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2669-73. PubMed ID: 12591953
[TBL] [Abstract][Full Text] [Related]
7. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.
Daly TM; Okuyama T; Vogler C; Haskins ME; Muzyczka N; Sands MS
Hum Gene Ther; 1999 Jan; 10(1):85-94. PubMed ID: 10022533
[TBL] [Abstract][Full Text] [Related]
8. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
Mango RL; Xu L; Sands MS; Vogler C; Seiler G; Schwarz T; Haskins ME; Ponder KP
Mol Genet Metab; 2004 May; 82(1):4-19. PubMed ID: 15110316
[TBL] [Abstract][Full Text] [Related]
9. Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of beta-glucuronidase.
Taylor RM; Wolfe JH
Nat Med; 1997 Jul; 3(7):771-4. PubMed ID: 9212105
[TBL] [Abstract][Full Text] [Related]
10. Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease.
Hofling AA; Devine S; Vogler C; Sands MS
Mol Ther; 2004 Jun; 9(6):856-65. PubMed ID: 15194052
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
[TBL] [Abstract][Full Text] [Related]
12. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
Sands MS; Barker JE; Vogler C; Levy B; Gwynn B; Galvin N; Sly WS; Birkenmeier E
Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
[TBL] [Abstract][Full Text] [Related]
13. Cross-correction of beta-glucuronidase deficiency by retroviral vector-mediated gene transfer.
Taylor RM; Wolfe JH
Exp Cell Res; 1994 Oct; 214(2):606-13. PubMed ID: 7925654
[TBL] [Abstract][Full Text] [Related]
14. Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease.
Hofling AA; Vogler C; Creer MH; Sands MS
Blood; 2003 Mar; 101(5):2054-63. PubMed ID: 12406886
[TBL] [Abstract][Full Text] [Related]
15. High level expression and export of beta-glucuronidase from murine mucopolysaccharidosis VII cells corrected by a double-copy retrovirus vector.
Wolfe JH; Kyle JW; Sands MS; Sly WS; Markowitz DG; Parente MK
Gene Ther; 1995 Jan; 2(1):70-8. PubMed ID: 7712336
[TBL] [Abstract][Full Text] [Related]
16. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII.
Sands MS; Erway LC; Vogler C; Sly WS; Birkenmeier EH
Blood; 1995 Sep; 86(5):2033-40. PubMed ID: 7655032
[TBL] [Abstract][Full Text] [Related]
17. Donor cell replacement in mice transplanted in utero is limited by immune-independent mechanisms.
Barker JE; Schuldt AJ; Lessard MD; Jude CD; Vogler CA; Soper BW
Blood Cells Mol Dis; 2003; 31(2):291-7. PubMed ID: 12972038
[TBL] [Abstract][Full Text] [Related]
18. Behavior and therapeutic efficacy of beta-glucuronidase-positive mononuclear phagocytes in a murine model of mucopolysaccharidosis type VII.
Freeman BJ; Roberts MS; Vogler CA; Nicholes A; Hofling AA; Sands MS
Blood; 1999 Sep; 94(6):2142-50. PubMed ID: 10477745
[TBL] [Abstract][Full Text] [Related]
19. Reduction of lysosomal storage in murine mucopolysaccharidosis type VII by transplantation of normal and genetically modified macrophages.
Ohashi T; Yokoo T; Iizuka S; Kobayashi H; Sly WS; Eto Y
Blood; 2000 Jun; 95(11):3631-3. PubMed ID: 10828055
[TBL] [Abstract][Full Text] [Related]
20. Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice.
Sakurai K; Iizuka S; Shen JS; Meng XL; Mori T; Umezawa A; Ohashi T; Eto Y
Gene Ther; 2004 Oct; 11(19):1475-81. PubMed ID: 15295619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
